Saba Capital Management, L.P. bought HQL
May 9, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 17,373 shares of Abrdn Life Sciences Investors at $13.80 per share, a transaction worth $239.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
17,373
Price
$13.80
Total value
$239.7K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 9, 2024
Filing dateMay 10, 2024
Shares owned after3,157,963
OwnershipIndirect
10b5-1 planNo
AmendedNo